single page -

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	5,466.30	1,788.60	6,217.60	22.33	-927.50	751.30	-137.50	2,438.60
2023-10-01	2023-12-31	5,399.70	1,299.80	5,758.20	27.12	-1,154.90	358.50	-175.50	1,759.40
2023-07-01	2023-09-30	5,752.10	1,489.60	6,112.80	32.56	-980.30	360.70	-154.30	2,005.20
2023-04-01	2023-06-30	5,313.60	935.30	5,648.20	20.44	-1,112.30	334.60	-155.50	1,257.50
2023-01-01	2023-03-31	5,726.40	1,296.50	6,040.20	28.34	-1,094.50	313.80	-264.10	1,647.20
2022-10-01	2022-12-31	6,217.50	1,506.60	6,491.60	32.93	-1,094.10	274.10	-263.40	2,006.80
2022-07-01	2022-09-30	6,374.70	3,110.70	6,617.10	67.99	-987.10	242.40	-262.50	4,152.20
2022-04-01	2022-06-30	5,929.00	325.50	6,109.20	7.11	-929.80	180.20	-265.10	433.90
2022-01-01	2022-03-31	5,496.60	1,257.90	5,667.80	27.50	-1,021.90	171.20	-336.10	1,451.10
2021-10-01	2021-12-31	6,759.00	1,439.10	6,941.60	31.46	-1,186.30	182.60	-271.60	1,840.90
2021-07-01	2021-09-30	6,362.60	1,429.50	6,512.90	31.25	-1,081.90	150.30	-272.30	1,749.60
2021-04-01	2021-06-30	7,491.70	1,999.10	7,614.10	43.69	-945.50	122.40	-270.00	2,687.30
2021-01-01	2021-03-31	5,347.60	1,005.50	5,719.60	21.98	-1,184.20	372.00	-273.10	1,320.90
2020-10-01	2020-12-31	5,934.90	1,412.40	6,080.60	30.87	-900.30	145.70	-272.30	1,802.60
2020-07-01	2020-09-30	5,954.10	1,313.70	6,075.60	28.71	-940.70	121.50	-277.30	1,830.30
2020-04-01	2020-06-30	5,148.90	1,244.50	5,320.90	27.20	-651.10	172.00	-271.40	1,733.40
2020-01-01	2020-03-31	5,020.10	1,030.10	5,472.30	22.52	-1,015.00	452.20	-284.10	1,219.00
2019-10-01	2019-12-31	5,381.80	1,390.60	5,964.00	30.40	-1,139.60	582.20	-247.00	1,645.00
2019-07-01	2019-09-30	5,670.60	1,542.50	6,118.10	33.72	-1,072.10	447.50	-251.30	1,811.80
2019-04-01	2019-06-30	5,444.00	1,128.10	5,802.30	24.66	-995.10	358.30	-250.00	1,749.10
2019-01-01	2019-03-31	5,356.60	1,094.70	5,711.10	23.93	-1,194.20	354.50	-176.10	1,682.20
2018-10-01	2018-12-31	5,137.90	1,319.40	5,781.40	28.84	-989.80	643.50	-177.70	2,006.20
2018-07-01	2018-09-30	5,197.40	958.00	5,568.00	-	-1,090.50	370.60	-177.30	1,488.80
2018-04-01	2018-06-30	5,123.10	918.40	5,428.40	-	-1,171.10	305.30	-182.80	1,421.90
2018-01-01	2018-03-31	5,199.50	1,045.10	5,511.80	-	-987.60	312.30	-172.70	1,525.40
2017-10-01	2017-12-31	4,565.40	872.40	4,886.20	-	-1,096.30	320.80	-177.30	1,320.80
2017-07-01	2017-09-30	5,711.10	1,111.50	5,948.20	-	-851.40	237.10	-160.20	1,747.70
2017-04-01	2017-06-30	4,325.90	571.70	4,598.60	-	-1,207.20	272.70	-152.30	885.20
2017-01-01	2017-03-31	4,531.70	680.40	4,819.70	14.87	-1,219.60	288.00	-	1,068.70
2016-10-01	2016-12-31	5,102.30	623.70	-	-	-1,379.20	265.20	-154.10	920.80
2016-07-01	2016-09-30	5,576.60	1,263.30	-	-	-1,284.40	243.00	-160.90	2,027.00
2016-04-01	2016-06-30	5,012.30	800.40	-	-	-1,284.50	215.40	-149.80	1,151.80
2016-01-01	2016-03-31	5,150.60	669.70	-	-	-1,363.50	283.80	-317.60	1,195.50
2015-10-01	2015-12-31	5,056.40	403.40	-	-	-1,404.30	243.70	-314.20	747.20
2015-07-01	2015-09-30	5,121.10	616.40	-	-	-1,326.80	161.90	-296.40	1,105.50
2015-04-01	2015-06-30	4,842.10	538.30	-	-	-1,159.00	168.00	-310.50	974.00
2015-01-01	2015-03-31	4,631.00	426.80	-	-	-1,192.00	187.70	-336.40	1,097.40
2014-10-01	2014-12-31	4,741.80	183.70	-	-	-1,566.70	172.30	-327.30	408.60
2014-07-01	2014-09-30	2,964.80	-118.30	-	-	-849.60	99.80	-19.00	-178.80
2014-04-01	2014-06-30	2,661.60	461.50	-	-	-721.00	100.80	-22.60	699.50
2014-01-01	2014-03-31	2,744.80	560.30	-	-	-746.10	163.10	-20.30	870.00
2013-10-01	2013-12-31	2,721.90	476.00	-	-	-841.30	281.30	-	727.10
2013-07-01	2013-09-30	2,989.70	695.90	-	-	-731.90	344.50	-21.90	1,067.60
2013-04-01	2013-06-30	2,661.60	476.30	-	-	-746.90	304.90	-20.10	731.10
2013-01-01	2013-03-31	2,817.40	581.60	-	-	-863.60	311.20	-19.20	841.30

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	5,466.30	1,788.60	6,217.60	22.33	-927.50	751.30	-137.50	2,438.60
2023-10-01	2023-12-31	5,399.70	1,299.80	5,758.20	27.12	-1,154.90	358.50	-175.50	1,759.40
2023-07-01	2023-09-30	5,752.10	1,489.60	6,112.80	32.56	-980.30	360.70	-154.30	2,005.20
2023-04-01	2023-06-30	5,313.60	935.30	5,648.20	20.44	-1,112.30	334.60	-155.50	1,257.50

Compounded Sales Growth
10 Years:	7%
5 Years:	1%
3 Years:	-1%
TTM:	-10%

Compounded Profit Growth
10 Years:	10%
5 Years:	5%
3 Years:	3%
TTM:	-9%

Stock Price CAGR
10 Years:	12%
5 Years:	6%
3 Years:	-7%
1 Year:	21%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	6%

Pfizer Ltd.

Short Description

Long Description

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Quarterly Table